Navigation Links
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Astex Pharmaceuticals, Inc.
Date:9/6/2013

BALA CYNWYD, Pa., Sept. 6, 2013 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Astex Pharmaceuticals, Inc. ("Astex" or the "Company") (Nasdaq: ASTX) relating to the proposed acquisition by Otsuka Pharmaceutical Co., Ltd. ("Otsuka").

Click here to learn more about the investigation http://brodsky-smith.com/635-astx-astex-pharmaceuticals-inc.html, or call: 877-534-2590. There is no cost or obligation to you.

Under the terms of the transaction, Astex shareholders will receive only $8.50 in cash for each share of Astex stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Astex for not acting in the Company's shareholders' best interests in connection with the sale process. The transaction may undervalue the Company as analysts have set price targets of $13.00 per share and $9.00 per share. In addition, the offer price is below the premium paid to shareholders in comparable transactions.

If you own shares of Astex common stock and wish to discuss the legal ramifications of the proposed transaction, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at investorrelations@brodsky-smith.com, by visiting http://brodsky-smith.com/635-astx-astex-pharmaceuticals-inc.html, or calling toll free 877-LEGAL-90. 

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and case action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome. 


'/>"/>
SOURCE Brodsky & Smith, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Buyout Alert -- Astex Pharmaceuticals -- Law Firm Seeks Higher Price For Shareholders
2. Hi Tech Shareholder Alert - Buyout Of Hi Tech - Law Firm Seeks Higher Price For Shareholders
3. Shareholder Alert: Pomerantz Law Firm has filed a Class Action Against Biolase, Inc. and Certain Officers - BIOL
4. Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. May Not Be in the Best Interests of Onyx Pharmaceuticals, Inc. Shareholders
5. Concord Medical Announces Acquisition of Its Shares by CEO and COO from Other Shareholders
6. OPTIMER PHARMACEUTICALS SHAREHOLDER ALERT: Levi & Korsinsky Investigates Possible Breaches of Fiduciary Duty by Board of Optimer Pharmaceuticals, Inc. in Connection with Sale of Company to Cubist Pharmaceuticals, Inc.
7. FDA Approvals, Dividends, New Technologies, and Solid Margins Increase Shareholder Value - Research Report on Abbott, Baxter, CareFusion, Haemonetics, and CR Bard
8. Teamsters Protest McKessons Worker Abuse And Executive Pay At Shareholder Meeting
9. Alliquas CEO Issues Midyear Corporate Update for Shareholders
10. Sinovac Schedules 2013 Annual Meeting of Shareholders
11. Millenia Hope, Inc. Updates to Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... July 11, 2017  Sysmex America, Inc., a ... testing equipment as well as middleware information systems ... to make quality assurance easier and more risk ... well known for the innovation that it delivers ... elevates quality assurance processes to a new level ...
(Date:7/10/2017)...  BDI Group subsidiary Pathway Purchasing Network, a ... serving specialty pharmacies, home infusion companies and physician ... value-added member programs designed to help organizations gain ... improve access and affordability for patients who rely ... Pathway has worked with ...
(Date:7/5/2017)... July 5, 2017 Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... has received approval from the Israel Securities Authority to dual-list ... Oramed common stock will commence trading on the TASE on ... current market capitalization of the Company, it is expected that ...
Breaking Medicine Technology:
(Date:7/21/2017)... Helena, AL (PRWEB) , ... July 21, 2017 ... ... that offers insurance assistance and financial planning services to communities in the greater ... that promises to provide resources to underprivileged young people in the region. , ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 , ... ... IL and Past President of the American Orthopaedic Society of Sports Medicine (AOSSM) ... 21, 2017 during the AOSSM Annual Meeting in Toronto, Canada. This prestigious award is ...
(Date:7/21/2017)... ... July 21, 2017 , ... “Kids aren't born knowing how to regulate their ... Suzanne Tucker, Founder of St. Louis-based positive education company Generation Mindful. To help with ... Monday, July 21st. , The kit uses colorful, engaging and educational illustrations and ...
(Date:7/21/2017)... ... July 21, 2017 , ... How ... are on the rise, say researchers presenting their work at the American ... , “The combination of evaluating the patterns of change in concussion symptom presentation, ...
(Date:7/20/2017)... ... July 20, 2017 , ... Coats ... is pleased to announce their expansion to the Midwest with the establishment of ... Hollis and Ronald Bell, and of counsels, John Peck and Robert Bruns, will ...
Breaking Medicine News(10 mins):